A detailed history of First City Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, First City Capital Management, Inc. holds 5,361 shares of NVS stock, worth $520,445. This represents 0.32% of its overall portfolio holdings.

Number of Shares
5,361
Previous 5,336 0.47%
Holding current value
$520,445
Previous $568,000 8.45%
% of portfolio
0.32%
Previous 0.32%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$106.13 - $120.89 $2,653 - $3,022
25 Added 0.47%
5,361 $616,000
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $92 - $107
1 Added 0.02%
5,336 $568,000
Q1 2024

May 22, 2024

SELL
$95.27 - $108.47 $5,906 - $6,725
-62 Reduced 1.15%
5,335 $516,000
Q4 2023

Feb 07, 2024

SELL
$92.27 - $101.54 $14,855 - $16,347
-161 Reduced 2.9%
5,397 $544,000
Q2 2023

Jul 19, 2023

SELL
$92.52 - $104.91 $18,504 - $20,982
-200 Reduced 3.47%
5,558 $560,000
Q1 2023

May 01, 2023

BUY
$80.03 - $92.81 $20,007 - $23,202
250 Added 4.54%
5,758 $529,000
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $18,887 - $23,130
-250 Reduced 4.34%
5,508 $499,000
Q3 2022

Oct 24, 2022

SELL
$74.61 - $87.26 $2,238 - $2,617
-30 Reduced 0.52%
5,758 $438,000
Q1 2022

May 04, 2022

BUY
$80.11 - $90.62 $12,096 - $13,683
151 Added 2.68%
5,788 $508,000
Q4 2021

Feb 07, 2022

SELL
$79.7 - $88.13 $93,647 - $103,552
-1,175 Reduced 17.25%
5,637 $486,000
Q2 2021

Aug 13, 2021

BUY
$85.24 - $94.15 $60,094 - $66,375
705 Added 11.54%
6,812 $633,000
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $835 - $984
-10 Reduced 0.16%
6,107 $535,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $315,871 - $382,063
-4,046 Reduced 39.81%
6,117 $564,000
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $369,712 - $409,591
4,501 Added 79.49%
10,163 $883,000
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $20,313 - $22,866
251 Added 4.64%
5,662 $494,000
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $3,533 - $4,950
-50 Reduced 0.92%
5,411 $446,000
Q4 2019

Feb 10, 2020

BUY
$84.35 - $95.37 $10,037 - $11,349
119 Added 2.23%
5,461 $517,000
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $5,046 - $5,561
-59 Reduced 1.09%
5,342 $464,000
Q1 2019

May 13, 2019

SELL
$75.32 - $86.15 $75,320 - $86,150
-1,000 Reduced 15.62%
5,401 $519,000
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $7,734 - $8,612
-105 Reduced 1.61%
6,401 $549,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,506
6,506 $543,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First City Capital Management, Inc. Portfolio

Follow First City Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First City Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First City Capital Management, Inc. with notifications on news.